Ensysce Biosciences, Inc. (ENSC) Operating margin 2020–2025
Ensysce Biosciences, Inc. (ENSC) operating margin by fiscal year — reported operating income divided by reported revenue.
-202.1%FY2025 · since FY2020: -41.0% → -202.1%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -202.1% | -72.9 pp |
| FY2024 | -129.2% | +351.3 pp |
| FY2023 | -480.5% | +479.4 pp |
| FY2022 | -959.9% | -397.2 pp |
| FY2021 | -562.7% | -521.7 pp |
| FY2020 | -41.0% | — |
Operating margin = reported operating income ÷ reported revenue for the same fiscal year. Operating-loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice
More ENSC financial trends
ENSC RevenueENSC Net incomeENSC Net marginENSC Gross profitENSC Gross marginENSC Operating incomeENSC Operating cash flowENSC Free cash flowENSC Capital expendituresENSC Return on equityENSC Stock buybacksENSC Dividends paidENSC Total assetsENSC Total liabilitiesENSC Shareholders’ equityENSC overview →